Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

Mihaela Skobe, Thomas Hawighorst, David G. Jackson et al. · Nature Medicine · 2001 · 1.7K citations

Medicine, Cancer Biology, Oncology +16

A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases.

Vladimir Joukov, Katri Pajusola, Arja Kaipainen et al. · The EMBO Journal · 1996 · 1.7K citations · Full text

Life Sciences, Cell Biology, Pharmacology +11

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Marc G. Achen, Michael Jeltsch, Eola Kukk et al. · Proceedings of the National Academy of Sciences · 1998 · 1.2K citations

Life Sciences, Bioinformatics, Molecular Biology +15

Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis

Stefano J. Mandriota · The EMBO Journal · 2001 · 980 citations · Full text

Medicine, Cancer Biology, Oncology +14

Fatty acid synthesis: a potential selective target for antineoplastic therapy.

Francis P. Kuhajda, K Jenner, F D Wood et al. · Proceedings of the National Academy of Sciences · 1994 · 703 citations

Life Sciences, Oncology, Cancer Pharmacology +15